-
1
-
-
0042377370
-
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
-
Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003; 42:775-80.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 775-780
-
-
Chan, K.L.1
Dumesnil, J.G.2
Cujec, B.3
-
2
-
-
39349106838
-
Effect of long-term aspirin use on embolic events in infective endocarditis
-
Chan KL, Tam J, Dumesnil JG, et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008; 46:37-41.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 37-41
-
-
Chan, K.L.1
Tam, J.2
Dumesnil, J.G.3
-
3
-
-
34247251422
-
Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis
-
Anavekar NS, Tleyjeh IM, Mirzoyev Z, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007; 44:1180-6.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 1180-1186
-
-
Anavekar, N.S.1
Tleyjeh, I.M.2
Mirzoyev, Z.3
-
4
-
-
0033151599
-
Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects
-
Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999; 99:2791-7.
-
(1999)
Circulation
, vol.99
, pp. 2791-2797
-
-
Kupferwasser, L.I.1
Yeaman, M.R.2
Shapiro, S.M.3
-
5
-
-
0042743989
-
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus
-
Kupferwasser LI, Yeaman MR, Nast CC, et al. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003; 112:222-33.
-
(2003)
J Clin Invest
, vol.112
, pp. 222-233
-
-
Kupferwasser, L.I.1
Yeaman, M.R.2
Nast, C.C.3
-
6
-
-
0033009042
-
Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis
-
Nicolau DP, Tessier PR, Nightingale CH. Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1999; 11:159-61.
-
(1999)
Int J Antimicrob Agents
, vol.11
, pp. 159-161
-
-
Nicolau, D.P.1
Tessier, P.R.2
Nightingale, C.H.3
-
7
-
-
33847309144
-
Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters
-
Sedlacek M, Gemery JM, Cheung AL, Bayer AS, Remillard BD. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007; 49:401-8.
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 401-408
-
-
Sedlacek, M.1
Gemery, J.M.2
Cheung, A.L.3
Bayer, A.S.4
Remillard, B.D.5
|